Malaria, a life-threatening disease caused by Plasmodium parasites transmitted through the bite of infected Anopheles mosquitoes, remains a significant public health challenge, particularly in tropical and subtropical regions. The parasite's complex life cycle involves stages in both mosquitoes and humans, leading to recurring bouts of fever, chills, and flu-like symptoms in infected individuals. Despite decades of efforts to control malaria through vector control measures, Despite advancements in antimalarial drugs and vaccine development, the disease continues to impose a significant burden, especially on vulnerable populations like pregnant women and children under five years old. The emergence of drug-resistant parasites and insecticide-resistant mosquitoes further complicates malaria control efforts, underscoring the need for continued research and innovation to combat this persistent threat to global health.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : A rare case of meningitis and septicemia due to Streptococcus acidominimus
Percival C Dilla, Region II Trauma and Medical Center, Philippines
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Association between cardiometabolic risk factors and COVID-19 severity in patients of a rural tertiary hospital
Percival C Dilla, Region II Trauma and Medical Center, Philippines